Expand patient access to new medical treatments and therapies that have not yet received full regulatory approval.
One policy goal, tracked across every bill that has carried it.
What’s happening with Access to Innovative Treatments Act of 2026?
The Access to Innovative Treatments Act of 2026 is currently H.R. 9418 and has sat in the House Ways and Means and Energy and Commerce committees since June 23, 2026. The members of these committees must act next to hold a vote, but the binding constraint is that most bills never receive a committee vote. History shows that committee inaction is how the vast majority of legislative proposals end.
Updated July 9, 2026 · Generated by AI. Always verify with official sources.
Where it stands
Now carried by Access to Innovative Treatments Act of 2026 (H.R. 9418 (119th)) →
Legislative Progress
Next up: A house committee · Nothing moves until they act.
How we got here
Every bill that has carried this goal, oldest first.
Died with Congress · Jan 3, 2025
Died when the 118th Congress ended without final passage. Bills must be reintroduced under a new number to be revived.
Reintroduced · Jan 3, 2025
Reintroduced from H.R. 2408 (118th), which died when its Congress ended.
H.R. 2408 (118th) →
Vehicles
Who’s behind it
Nanette Barragán (D-CA)Wrote and sponsored the current bill.